Ding Y, Oliveira-Ferrer L, Vettorazzi E, Legler K, et al. VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients. PLoS One 2022;17:e0269680.
PMID: 35687576